SkinBioTherapeutics – identifies blends for acne consumer study, an upcoming catalysts STRONG BUY
By HotStockRockets | Saturday 9 September 2023
Disclosure: I own shares in one or more of the stocks mentioned. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.
SkinBioTherapeutics (SBTX) has announced that it has chosen the probiotic blends it will use for a consumer study in acne which is expected to commence in the next quarter and be complete by year-end.
Premium content is for paid subscribers only
ShareProphets is reader-supported journalism
Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.